Join
Live feed
·
INSIDERFilingvia Quantisnow
Sage Therapeutics Inc. logo

Chief Business Officer Benecchi Christopher was granted 16,200 shares and covered exercise/tax liability with 4,755 shares, increasing direct ownership by 163% to 18,487 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
SAGE· Sage Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SAGE (Sage Therapeutics Inc.) and more on Quantisnow.